Saturday 17 October 2026
Export CLPT’s income statement to Excel — free account
ClearPoint Neuro, Inc.
CLPT Healthcare Medical Devices
ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS fell 81.0%, free cash flow fell 173.5% and total debt rose 74.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
9.07
0.57
−5.91%
Follow CLPT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 4 | 4 | 3 |
+8 more TTM periods Free account |
| (226.52%) | (149.72%) | (95.64%) | (103.13%) | ||
| (46.21%) | (47.08%) | (37.30%) | (46.03%) | ||
ROIC |
(61.31%) | (50.31%) | (48.45%) | (207.44%) | |
Return on Tangible Assets |
(83.08%) | (60.16%) | (46.05%) | (50.98%) | |
Average Days of Receivables |
72.48 | 77.85 | 64.66 | 42.53 | |
Free Cash Flow per Share |
(1.04) | (0.90) | (0.86) | (0.49) | |
Free Cash Flow |
(31.29) | (26.70) | (24.45) | (13.82) | |
Capital Expenditures |
(1.11) | (0.98) | (0.52) | (0.74) | |
| Other line items | |||||
Cash ROIC |
(34.62%) | (25.66%) | (19.87%) | (16.60%) | |
Accounts Receivable Turnover |
6.68 | 6.60 | 6.57 | 8.72 | |
Accounts Payable Turnover |
8.58 | 8.63 | 11.00 | 15.83 | |
Inventory Turnover |
2.09 | 2.02 | 1.88 | 1.95 | |
Average Days of Payables |
49.71 | 55.59 | 32.11 | 19.87 | |
Days of Inventory on Hand |
203.48 | 204.55 | 213.67 | 180.91 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
37.47% | 37.03% | 37.59% | 40.75% | |
Selling, General and Administrative Expense of Revenue |
98.56% | 90.50% | 89.15% | 86.84% | |
Share Based Compensation of Revenue |
20.09% | 20.90% | 22.13% | 23.02% | |
Interest Coverage |
(5.99) | (6.84) | (9.41) | — | |
Operating CF/Net income |
0.87 | 0.88 | 0.94 | 0.57 | |
Depreciation/Fixed assets |
1.31 | 1.08 | 0.89 | 0.91 | |
Capex/Depreciation |
(0.28) | (0.31) | (0.22) | (0.38) | |
Revenue per Share |
1.40 | 1.37 | 1.31 | 1.21 | |
Operating CF per Share |
(1.00) | (0.87) | (0.84) | (0.46) | |
Capex per Share |
(0.04) | (0.03) | (0.02) | (0.03) | |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.02 |
Columns are period end dates